New Book: ACTA And The Plurilateral Enforcement Agenda: Genesis And Aftermath

ACTA book Roffe

The new book, “The ACTA and the Plurilateral Enforcement Agenda,” offers an insightful read on the highly debated Anti-Counterfeiting Trade Agreement (ACTA), an effort to raise intellectual property protection that was met with opposition by many countries and was subject to intense scrutiny from non-state actors, including industry, civil society and academics.

Revolving Chairs In The IP World: People Shift Positions. But Interests? Not So Much

Crowd-1-Stan-Douglas-850x504

A lot has happened among the global intellectual property community over the past months. Beyond the usual shifts in law offices, many key positions have either changed hands or been filled. For example, the European commissioners changed, and the United States nominated a new “piracy czar” and a new head of the US Patent and Trademark Office. The International Telecommunication Union, UNITAID and other organisations have new heads. And the World Intellectual Property Organization has a new top management team.

Non-governmental organisations and the private sector also saw a lot of movement in recent months, such as the Electronic Frontier Foundation, the Computer & Communications Industry Association, the International Trademark Association, the International Publishers Association, and the Motion Picture Association of America.

In this article, we take the opportunity to catch up. Here is a look at some of the changes.

EU IP Policy Proposals, Initiatives Come Clear At 20th European IP Forum

Christian Peugeot gives the opening speech of the event, photo credit: 20ème Forum Européen de la Propriété Intellectuelle par l’Union des Fabricants

PARIS – A recent gathering of IP owners, lawyers and government officials explored strategies and potential policies to fight counterfeiting and piracy.

South Africa Awaits Patent Reforms With Hope, Concern

Fix the Patent Laws image

CAPE TOWN – South Africa’s new policy on patents could go to the Cabinet for approval soon, says Doctors without Borders (Médecins Sans Frontières, MSF), one of the organisations spearheading the Fix the Patent Laws campaign in the country.

In 21st Century No One Should Die For Lack Of Access To Medicines, Participants At UN Forum Say

Price of Medicines

Last week’s 2015 Social Forum led by the UN Office of the High Commissioner for Human Rights (OHCHR) called for urgent action to facilitate access to medicines. In particular, the functioning of the intellectual property system was put into question. A number of recommendations were drawn by the secretariat after having been identified by participants.

Stakeholders Give Opposing Views On GIs In EU-US Trade Agreement

GI cheese image

Geographical indications – product names deriving from geographical origin or certain characteristics – are increasingly on the table when trade negotiations include Europeans, who are trying to recover names long used around the world. In a recent stakeholder event for the Transatlantic Trade and Investment Partnership (TTIP), both sides of the GI issue made their case.

US Challenges For Biotech In 2015 – An Interview With BIO’s Hans Sauer

Hans Sauer

The biotechnology industry is closely watching developments in the United States that could impact the industry in 2015. These include the regulatory framework for biosimilars, possible patent legislation, post-grant review procedure, and the consequences of the recent Supreme Court ruling banning the patenting of human genes. Hans Sauer, Deputy General Counsel for Intellectual Property at the Biotechnology Industry Organization (BIO), recently spoke with Intellectual Property Watch’s Catherine Saez. Sauer was asked to lay out the main developments to watch in the coming year.

Questions About Funding, Text Of Tufts Study On Drug Costs

UACT-300dpi-small

The Union for Affordable Cancer Treatment has sent a letter to the author of a much-noted Tufts University (US) study that found high development costs for medicines, with copies to the university administration. The letter requests transparency on the funding of the study and the press conference announcing the results, as well as copies of the study itself, which the group says was not made public, along with details to justify the result.

WHO Sets Path For Completing Rules Of Engagement With Industry, Foundations

lobbying hand image

The World Health Organization Executive Board has set a way forward from now to the annual May World Health Assembly for addressing the sensitive issue of drafting a framework for engagement with “non-state actors,” such as industry, foundations, academics and other non-governmental stakeholders.

Anti-Microbial Resistance, Budget, Reform Raise Debate At WHO Executive Board

Public Health - Bacteria

The World Health Organization Executive Board this week has addressed the relationship between the UN agency and its funders and lobbyists, examined the budget for the next biennium, and looked at the issue of the growing resistance of bacteria to antibiotics. Image Credits: Flickr – NIAID